| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $0.97 (Beat by $0.13) |
| EPS GAAP Actual | $0.97 (Beat by $0.13) |
| Revenue Actual | $1.3602B |
| Revenue Surprise | Beat by $1360.2M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 15 | 4.38 | 14.34996 | 15.76078 | 1 |
| Dec 2026 | 2.4467 | 26.87 | 2.279 | 2.594 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -3.58 | -3.58 | 1.3602B | 6.39% | 1360.2M |
| FQ2 2025 (Jun 2025) | 65.79 | 65.79 | 1.447B | 0.21% | 1447M |
| FQ1 2025 (Mar 2025) | 66.2 | 66.2 | 1.2218B | -11.72% | 1221.8M |
| FQ4 2024 (Dec 2024) | -1.07 | -1.07 | 1.1549B | -17.92% | 1154.9M |
| FQ3 2024 (Sep 2024) | 0.66 | 0.66 | 1.2733B | -33.69% | 1273.3M |
| FQ2 2024 (Jun 2024) | 1.48 | 1.48 | 1.4439B | 100% | 1443.9M |
| FQ1 2024 (Mar 2024) | 68.3 | 68.3 | 1.365B | -27.74% | 1365M |
| FQ4 2023 (Dec 2023) | 68.9 | 68.9 | 1.3619B | -16.21% | 1361.9M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.965 | -- | 0.92979 | 1.00099 | 4 |
| FQ3 2027 (Sep 2027) | 1.325 | -- | 1.27666 | 1.37442 | 4 |
| FQ2 2027 (Jun 2027) | 1.66 | -- | 1.59944 | 1.72192 | 4 |
| FQ1 2027 (Mar 2027) | 0.955 | -- | 0.92016 | 0.99062 | 4 |
| FQ4 2026 (Dec 2026) | 0.69852 | -- | 0.67304 | 0.72457 | 2 |
| FQ3 2026 (Sep 2026) | 1.22074 | 393.26 | 1.1762 | 1.26627 | 2 |
| FQ2 2026 (Jun 2026) | 2.23 | -2850.22 | 2.23 | 2.23 | 10 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.32B | -- | 1.28B | 1.36B | 4 |
| FQ3 2027 (Sep 2027) | 1.47B | -- | 1.43B | 1.51B | 5 |
| FQ2 2027 (Jun 2027) | 1.6B | -- | 1.56B | 1.65B | 6 |
| FQ1 2027 (Mar 2027) | 1.38B | -- | 1.34B | 1.42B | 3 |
| FQ4 2026 (Dec 2026) | 1.26B | -- | 1.22B | 1.3B | 3 |
| FQ3 2026 (Sep 2026) | 1.4B | 2.95 | 1.36B | 1.44B | 3 |
| FQ2 2026 (Jun 2026) | 1.6B | 9.55 | 1.6B | 1.6B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -3.58 | -3.58 | 100% | |
| FQ2 2025 (Jun 2025) | 65.79 | 65.79 | 100% | |
| FQ1 2025 (Mar 2025) | 66.2 | 66.2 | 100% | |
| FQ4 2024 (Dec 2024) | -1.07 | -1.07 | 100% | |
| FQ3 2024 (Sep 2024) | 0.66 | 0.66 | 100% | |
| FQ2 2024 (Jun 2024) | 1.48 | 1.48 | 100% | |
| FQ1 2024 (Mar 2024) | 68.3 | 68.3 | 100% | |
| FQ4 2023 (Dec 2023) | 68.9 | 68.9 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.36B | $1360.2M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.45B | $1447M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.22B | $1221.8M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.15B | $1154.9M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.27B | $1273.3M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.44B | $1443.9M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.37B | $1365M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.36B | $1361.9M | 100% |